IDO1 and cholangiocarcinoma: Notably, the altered expression of IDO1 (hazard ratio (HR): 3.47; 95% confidence interval (CI): 1.22~9.91; log-rank equal curves p = 0.013) in the 35-CCA-patient cohort was linked with overall worse survival (Figure 2D).